BIAXIN
BGP PHARMA ULC
Quick answers
Is there a shortage of BIAXIN in Canada?
No. There is no current shortage of BIAXIN 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
BIAXIN BID
BGP PHARMA ULC
RATIO-CLARITHROMYCIN
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
M-CLARITHROMYCIN
MANTRA PHARMA INC
RAN-CLARITHROMYCIN
SUN PHARMA CANADA INC
BIAXIN
BGP PHARMA ULC
SANDOZ CLARITHROMYCIN
SANDOZ CANADA INCORPORATED
DIN
02244641
Strength
250MG
Dosage Form
GRANULES FOR SUSPENSION
Route
ORAL
Compare with another product →
Shortage History
Demand increase for the drug.
Other (Please describe in comments)
Demand increase for the drug.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.